0085-1334 : Clarinex .5 mg/ml Oral Solution


NDC0085-1334
Labeler: Merck Sharp & Dohme Corp.
Product Type: Human Prescription Drug
Drug Name:  Clarinex
Dosage Form: Oral Solution
Application #: NDA021300
Rev. Date: 


NDC Package Codes:

  • 0085-1334-01: 1 BOTTLE IN 1 CARTON (0085‑1334‑01) > 473 ML IN 1 BOTTLE
  • 0085-1334-02: 1 BOTTLE IN 1 CARTON (0085‑1334‑02) > 118 ML IN 1 BOTTLE

Active Ingredients:

  • Desloratadine

Dosage Strength:

  • .5 mg/mL

Pharmaceutical Classes:

  • Histamine H1 Receptor Antagonists [MoA]
  • Histamine-1 Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 0085-1264 Clarinex 5 mg Oral Tablet by Merck Sharp & Dohme Corp.
  • 21695-815 Clarinex 5 mg Oral Tablet by Rebel Distributors Corp
  • 50090-0765 Clarinex 5 mg Oral Tablet, Film Coated by A-s Medication Solutions
  • 54868-4624 Clarinex 5 mg Oral Tablet by Physicians Total Care, Inc.
  • 78206-119 Clarinex 5 mg Oral Tablet, Film Coated by Organon LLC
  • 78206-188 Clarinex 5 mg Oral Tablet, Film Coated by Organon LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0085-1334 QR Code

< Prev: 0085-1328Next: 0085-1341 >

Related Discussions:

Clarinex-d 24hour
My health insurance to longer covers this drug where can it be purchased? ## Hi Birdie, Even if your health insurance no... 1 reply
Lisinopril, Clarinex, Prilosec and Pregnancy
Can I take this medications during the first trimester of my pregnancy? ## As of 2 days ago, I was diagnosed with hypert... 3 replies
clarinex
Caplet blue with K19 on the pill ## I need to know if a pill I have is clarinex. It is a blue caplet with K19 on it. ## ... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.